bibliographic entry 3814417 [be/3814417]
https://w3id.org/oc/corpus/be/3814417

is a
content
  • Hennessy BT, Timms KM, Carey MS et al: Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancer. J Clin Oncol 2010; 28: 3570–3576. PMID: 20606085
references